Surmodics | SRDX - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 26B 1.16B 2025-12
Align Technology USD 2.62B 82.47M 2025-12
Anika Therapeutics USD 103.36M 1.77M 2025-12
Arrowhead Research USD 1.17B 223.75M 2025-12
Artivion USD 358.08M 20.58M 2025-12
Baxter International USD 6.87B 61M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
EDAP TMS EUR 44.35M 7.13M 2025-09
Edwards Lifesciences USD 6.36B 218.3M 2025-09
Haemonetics USD 943.67M 43.99M 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
J&J USD 55.62B 1.01B 2025-12
Merit Medical Systems USD 1.04B 54.62M 2025-12
Mesa Laboratories USD 105.63M 8.2M 2025-12
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Option Care Health USD 1.26B 17.8M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Surmodics USD 75.99M 5.31M 2025-06
Trinity Biotech USD 35.52M 2.52M 2025-09